This is how it's going to go with antibody treatments, like most of the response to this pandemic has gone....in an uneven, ad hoc manner. And skewed favorably towards those with money and connections. It's very frustrating to see these drug companies produce hundreds of thousands, even over a million doses of what could be successful treatment for certain COVID patients, only to have it left to the states to try to distribute. These treatment needs to be distributed very early to COVID positive patients who are at a particularly high risk of a bad outcome. With our really poor testing and tracing record, it's not likely that this will help those most in need.
I read an article about a local man who survived COVID after 174 days in the hospital. He looked to be in his 50s, had a son in the photo...maybe 10 years old. The article didn't focus on him so much, as it did our local Congressman, who this family contacted on two occasions.....to get Remdesivir for this man, and also to get him convalescent plasma. The family credited the Congressman's phone calls to the right people as a life-saving intervention. It likely did save his life. The average person isn't getting that kind of assistance from their local congressman.
https://www.nytimes.com/2020/10/20/health/covid-antibody-regeneron.html?searchResultPosition=3
